Tablet-based Aphasia Therapy in the Chronic Phase

NCT ID: NCT03622411

Last Updated: 2023-01-10

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

15 participants

Study Classification

INTERVENTIONAL

Study Start Date

2018-09-07

Study Completion Date

2021-02-23

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Aphasia is one of the most common and disabling disorders following stroke, in many cases resolving in long-term deficits. There is evidence that intensive aphasia therapy is effective for language recovery, even in the chronic phase post-stroke. However, as many patients are left with residual language disorders and intensive aphasia rehabilitation is difficult to achieve, the investigators are exploring tablet-based therapies to further facilitate language recovery in a cost-effective manner.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This study will investigate the clinical effects of intensive tablet-based aphasia therapy as an add-on to conventional aphasia therapy (= high intensive) compared to conventional aphasia therapy (either alone, or in combination with recreational tablet use (= low intensive) in patients with aphasia following stroke, as measured by specific linguistic tests, within task improvements, functional communication and quality of life.

Furthermore, the investigators want to learn more about the recovery of specific underlying language processes via event-related potentials (ERPs). At last, the investigators aim to explore whether patients with aphasia are satisfied with a tablet-based aphasia therapy, whether the app is user-friendly and which barriers the participants might have encountered.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Aphasia Stroke

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

aphasia therapy + speech app

3 hours per week of conventional aphasia therapy during 3 weeks + 5 hours per week during 3 weeks independent practice via the speech app

Group Type EXPERIMENTAL

speech app

Intervention Type DEVICE

language exercises provided by the speech therapist in hospital + independent practice of language exercises via a tablet and speech app

aphasia therapy

Intervention Type BEHAVIORAL

language exercises provided by the speech therapist in hospital

aphasia therapy + brain games

3 hours per week of conventional aphasia therapy during 3 weeks + 5 hours per week during 3 weeks of recreational tables use (brain games)

Group Type ACTIVE_COMPARATOR

brain games

Intervention Type DEVICE

language exercises provided by the speech therapist in hospital + independent recreational tablet use via brain games

aphasia therapy

Intervention Type BEHAVIORAL

language exercises provided by the speech therapist in hospital

aphasia therapy

3 hours per week of conventional aphasia therapy during 3 weeks

Group Type ACTIVE_COMPARATOR

aphasia therapy

Intervention Type BEHAVIORAL

language exercises provided by the speech therapist in hospital

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

speech app

language exercises provided by the speech therapist in hospital + independent practice of language exercises via a tablet and speech app

Intervention Type DEVICE

brain games

language exercises provided by the speech therapist in hospital + independent recreational tablet use via brain games

Intervention Type DEVICE

aphasia therapy

language exercises provided by the speech therapist in hospital

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* diagnosed with mild-severe aphasia (token test score between 7 and 49) after a left hemispheric ischemic or hemorrhagic stroke
* inclusion starting from 6 months post-stroke
* age 18 - 85 years
* being right-handed (according to the questionnaire for handedness, Van Strien)
* mother tongue: Dutch
* imaging (CT or MRI) prior to inclusion
* signed informed consent

Exclusion Criteria

* history of a previous stroke with persistent (\> 24 hours) language symptoms
* history of other diseases of the central nervous system, psychological disorders and (developmental) speech and/or language disorders
* serious non-linguistic, cognitive disorders (as documented in the patients' medical history)
* inability to perform tablet-based tasks (based on a short training session)
* excessive use of alcohol or drugs
Minimum Eligible Age

18 Years

Maximum Eligible Age

85 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University Hospital, Ghent

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Veerle De Herdt

Role: PRINCIPAL_INVESTIGATOR

University Ghent

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University Hospital, department of neurology

Ghent, , Belgium

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Belgium

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

EC/2018/0909

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Clinic and Neurophysiology of Aphasia Treatment
NCT05572385 NOT_YET_RECRUITING NA
TMS in Aphasia Recovery
NCT04777214 COMPLETED NA